Evidence map›Paper›PMID 30959841›Full record

ReviewAntioxidants (Basel, Switzerland)2019

Juglone in Oxidative Stress and Cell Signaling.

Taseer Ahmad, Yuichiro J Suzuki

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 161 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Nutraceutical potential of moroccanFrontiers in chemistry · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Taseer AhmadCollege of Pharmacy, University of Sargodha, Sargodha, Punjab 40100, Pakistan. drtasir2011@gmail.com.
Yuichiro J SuzukiDepartment of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20007, USA. ys82@georgetown.edu.
Georgetown University Medical Center · USUniversity of Sargodha · PK

Funding

Mechanism of apoptosis in lung vascular smooth muscleR01HL072844 · NHLBI · TUFTS UNIVERSITY BOSTON · PI SUZUKI, YUICHIRO JUSTIN · 2003 to 2017
$3.3M
New mechanism of cellular protein oxidationR21AI142649 · NIAID · GEORGETOWN UNIVERSITY · PI SUZUKI, YUICHIRO JUSTIN · 2019 to 2020
$428k
Oxidant-mediated amino acid conversions in alcohol abuseR03AA026516 · NIAAA · GEORGETOWN UNIVERSITY · PI SUZUKI, YUICHIRO JUSTIN · 2019 to 2020
$156k
Endogenous protein engineering mechanismof oxidative stress in Alzheimer's diseaseR03AG059554 · NIA · GEORGETOWN UNIVERSITY · PI SUZUKI, YUICHIRO JUSTIN · 2018 to 2019
$156k
National Institutes of Health R01HL072844, R21AI142649, R03AG059554, R03AA026516NHLBI NIH HHS R01 HL072844NIAAA NIH HHS R03 AA026516NIAID NIH HHS R21 AI142649NIA NIH HHS R03 AG059554
6 · The paper itself

Abstract

Juglone (5-hydroxyl-1,4-naphthoquinone) is a phenolic compound found in walnuts. Because of the antioxidant capacities of phenolic compounds, juglone may serve to combat oxidative stress, thereby protecting against the development of various diseases and aging processes. However, being a quinone molecule, juglone could also act as a redox cycling agent and produce reactive oxygen species. Such prooxidant properties of juglone may confer health effects, such as by killing cancer cells. Further, recent studies revealed that juglone influences cell signaling. Notably, juglone is an inhibitor of Pin1 (peptidyl-prolyl

Indexed as

antioxidantsjuglonenaphthoquinonePin1redoxsignal transductionwalnuts

Identifiers

PMID30959841
PMCPMC6523217
OpenAlexW2932792578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.